Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangshan Chen

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Immunopharmacology|January 19, 2020
Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma)Yu Sun, Jiping Luo, Yangshan Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2022
A whole-slide image (WSI)-based immunohistochemical feature prediction system improves the subtyping of lung cancerYanyang Chen, Huan Yang, Zhiqiang Cheng, et al.
Oncology Letters|May 8, 2018
Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinomaXiaopeng Mao, Baimou Li, Ying Liang, et al.
Thoracic Cancer|December 7, 2018
Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinibKejing Tang, Neng Jiang, Yukun Kuang, et al.
Theranostics|March 21, 2020
HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signalingNeng Jiang, Chang Zou, Ying Zhu, et al.
Journal of Translational Medicine|January 20, 2019
Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinomaWeiling He, Di Xu, Zhuo Wang, et al.
BMC Cancer|April 11, 2018
CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9Weiling He, Hui Zhang, Yuefeng Wang, et al.
International Journal of Cancer|August 3, 2018
Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinomaWeiling He, Minzhi Hou, Hui Zhang, et al.
Biomaterials Science|January 19, 2019
The role of a semi-automated NanoVelcro system in capturing circulating tumor cells and evaluating their prognostic value for gestational choriocarcinomaMinzhi Hou, Yongjiang Zheng, Zhiming Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter StudyYongmei Cui, Wenfeng Fang, Chaofeng Li, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Immunopharmacology|January 19, 2020
Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma)Yu Sun, Jiping Luo, Yangshan Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2022
A whole-slide image (WSI)-based immunohistochemical feature prediction system improves the subtyping of lung cancerYanyang Chen, Huan Yang, Zhiqiang Cheng, et al.
Oncology Letters|May 8, 2018
Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinomaXiaopeng Mao, Baimou Li, Ying Liang, et al.
Thoracic Cancer|December 7, 2018
Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinibKejing Tang, Neng Jiang, Yukun Kuang, et al.
Theranostics|March 21, 2020
HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signalingNeng Jiang, Chang Zou, Ying Zhu, et al.
Journal of Translational Medicine|January 20, 2019
Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinomaWeiling He, Di Xu, Zhuo Wang, et al.
BMC Cancer|April 11, 2018
CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9Weiling He, Hui Zhang, Yuefeng Wang, et al.
International Journal of Cancer|August 3, 2018
Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinomaWeiling He, Minzhi Hou, Hui Zhang, et al.
Biomaterials Science|January 19, 2019
The role of a semi-automated NanoVelcro system in capturing circulating tumor cells and evaluating their prognostic value for gestational choriocarcinomaMinzhi Hou, Yongjiang Zheng, Zhiming Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter StudyYongmei Cui, Wenfeng Fang, Chaofeng Li, et al.
Pageof 2